Hologic, Inc. (HOLX)
NASDAQ: HOLX · Real-Time Price · USD
75.19
+0.19 (0.25%)
Dec 15, 2025, 4:00 PM EST - Market closed
Hologic Stock Forecast
Stock Price Forecast
The 11 analysts that cover Hologic stock have a consensus rating of "Hold" and an average price target of $79.64, which forecasts a 5.92% increase in the stock price over the next year. The lowest target is $70 and the highest is $90.
Price Target: $79.64 (+5.92%)
Analyst Consensus: Hold
* Price targets were last updated on Nov 11, 2025.
Analyst Ratings
The average analyst rating for Hologic stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 2 | 2 | 2 | 2 |
| Buy | 4 | 5 | 5 | 2 | 2 | 2 |
| Hold | 8 | 7 | 7 | 11 | 11 | 11 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13 | 13 | 14 | 15 | 15 | 15 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Hold Maintains $69 → $76 | Hold | Maintains | $69 → $76 | +1.08% | Nov 11, 2025 |
| Mizuho | Mizuho | Buy → Hold Downgrades $70 → $78 | Buy → Hold | Downgrades | $70 → $78 | +3.74% | Oct 23, 2025 |
| Raymond James | Raymond James | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Oct 22, 2025 |
| Stephens & Co. | Stephens & Co. | Buy → Hold Downgrades $78 → $76 | Buy → Hold | Downgrades | $78 → $76 | +1.08% | Oct 22, 2025 |
| JP Morgan | JP Morgan | Buy → Hold Downgrades $78 | Buy → Hold | Downgrades | $78 | +3.74% | Oct 22, 2025 |
Financial Forecast
Revenue This Year
4.38B
from 4.10B
Increased by 6.69%
Revenue Next Year
4.63B
from 4.38B
Increased by 5.74%
EPS This Year
4.64
from 2.49
Increased by 86.42%
EPS Next Year
5.11
from 4.64
Increased by 10.02%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 4.5B | 4.8B | ||
| Avg | 4.4B | 4.6B | ||
| Low | 4.1B | 4.4B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 10.6% | 9.8% | ||
| Avg | 6.7% | 5.7% | ||
| Low | 0.9% | 0.7% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 4.88 | 5.44 | ||
| Avg | 4.64 | 5.11 | ||
| Low | 4.31 | 4.74 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 96.1% | 17.2% | ||
| Avg | 86.4% | 10.0% | ||
| Low | 73.2% | 2.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.